CoChat

Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients

SHRIVASTAVA, RAM K., COHN, CAL, CROWDER, JOHN, DAVIDSON, JONATHAN, DUNNER, DAVID, FEIGHNER, JOHN, KIEV, ARI, PATRICK, ROGER · 1994 · Journal of Clinical Psychopharmacology
Cited by 67

The DOI matches its Crossref record.

Abstract

The antidepressant efficacy and safety of venlafaxine was shown previously in 6-week, placebocontrolled trials. We evaluated the long-term safety and clinical acceptability of venlafaxine and imipramine in a double-blind, parallel-group, comparative study. Two hundred ninety depressed outpatients were treated with venlafaxine, and an additional 91 received imipramine for as long as clinically necessary, up to 1 year. The total daily dose of each drug could vary from 75 to 225 mg. The Clinical Global Impressions Scale and a therapeutic response rate that was based on Clinical Global Impressions Scale-Improvement and incorporated discontinuation information were used to evaluate efficacy. Safety determinations and patient subjective ratings were used to evaluate safety and clinical acceptability. During the study, the adverse events were generally mild to moderate and most subsided with continued treatment; the most frequent were nausea for venlafaxine and dry mouth for imipramine. The anticholinergic side effect burden was significantly higher in the imipramine group than in the venlafaxine group. Venlafaxine was judged significantly more acceptable than imipramine, on the basis of the subjective ratings by patients. Fewer venlafaxinetreated patients than imipramine-treated patients withdrew because of adverse events and unsatisfactory response. There was a consistent trend in the therapeutic response rates in favor of venlafaxine that reached statistical significance at months 2, 6, and 12. In this long-term study, patient acceptability was greater for venlafaxine than for imipramine, suggesting therapeutic advantages for venlafaxine in the long-term treatment of depression. Additional studies with other active comparators are underway to confirm and extend these encouraging results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199410000-00006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 67

Metadata

Authors
SHRIVASTAVA, R. K., COHN, C., CROWDER, J., DAVIDSON, J., DUNNER, D., FEIGHNER, J., KIEV, A., & PATRICK, R.
Venue
Journal of Clinical Psychopharmacology
Published
1994-10
Volume
14
Issue
5
Pages
322???329
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2010757126
Cited by
67
References
0
FWCI
7.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients. https://app.cochat.ai/papers/10.1097/00004714-199410000-00006
The paper
SHRIVASTAVA, R. K., COHN, C., CROWDER, J., DAVIDSON, J., DUNNER, D., FEIGHNER, J., KIEV, A., & PATRICK, R. (1994). Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199410000-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.